EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HepaRGTM CYP induction test method augmentation part 2: Study supported by mRNA analysis

Emma Quartermain, Jinkang Zhang, Tim Marczylo, Timothy W Gant, Miriam N Jacobs

ALTEX - Alternatives to Animal Experimentation · 2026

DOI: 10.14573/altex.2606132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ALTEX - Alternatives to Animal Experimentation, 2026. Verfasst von Emma Quartermain und 4 weiteren Autor:innen. Beteiligte Einrichtung: UK Health Security Agency, Dept of Toxicology, Radiation, Chemical, Climate and Environmental Hazards (RCCE), Harwell Campus, Chilton, United Kingdom. Hauptthemen laut MEDLINE: RNA, Messenger, Animal Testing Alternatives, Cytochrome P-450 Enzyme System, Cytochrome P-450 Enzyme Inducers. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytochrome P450 (CYP)-mediated biotransformation of endogenous and xenobiotic substances can lead to altered exposure, toxicological impact, or adverse drug reactions. CYP induction data are fundamental to regulatory chemical hazard assessment because they directly affect the in vivo fate of xenobiotics, potentially influencing the safety and efficacy of pharmaceuticals, and impacting the safety assessment of industrial chemicals and environmental contaminants. Here we report the results on part 2 of the supplementary validation study of an established and previously validated in vitro method using human HepaRGTM cells able to detect CYP1A2, CYP2B6 and CYP3A4 induction to support the expansion of the method’s chemical applicability domain beyond pharmaceuticals. This study addresses needs arising from part 1 of the study. We established the test method using ten previously validated pharmaceutical proficiency chemicals, then tested a further six proposed augmentation chemicals, tebuconazole, benfuracarb, chlorpyrifos, N, N-diethyl-meta-toluamide, fipronil, and permethrin (supporting part 1), and then four additional chemicals, prochloraz, atrazine, pyrimethanil and chlorpyrifos-methyl. LC-MS/MS was utilized to measure the conversion of a cocktail mixture of prototypical selective CYP probe substrates to their metabolites, in parallel with mRNA measurements. We achieved high concordance with predicted activity for the proficiency and augmentation chemicals for CYP1A2 and CYP3A4, though with greater uncertainty for CYP2B6. Together with the part 1 study, these data were sufficient to support acceptance of the HepaRG™ method for CYP induction testing and its adoption as OECD TG 445A. Tentative comparisons with mRNA based measurements suggested gene expression may serve as a complementary but not validated tool. Plain language summaryCytochrome P450 (CYP) enzymes break down drugs, pesticides and other chemicals in the liver. Increases or decreases in CYP activity caused by certain chemicals can change internal levels of other chemicals, which can cause toxicity or impact drug effectiveness. Reliable non-animal methods are needed to identify chemicals with this activity for chemical safety assessment. This study describes results from a replacement second laboratory applying a previously validated human HepaRG™ cell‑based method to assess induction of CYP1A2, CYP2B6, and CYP3A4 by ten reference pharmaceutical compounds and ten industrial chemicals. CYP induction was evaluated by measuring enzyme activity. These results strengthen confidence in the method’s robustness and wider applicability and have supported its adoption as an OECD Test Guideline. The method showed a high level of agreement with expected outcomes particularly for CYP1A2 and CYP3A4. Additional exploration of changes in gene expression supported enzyme activity results but was not validated here.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerAnimal Testing AlternativesCytochrome P-450 Enzyme SystemCytochrome P-450 Enzyme InducersHumansHepatocytesCell LineCytochrome P-450 CYP2B6Cytochrome P-450 CYP3A

Stichwörter der Autor:innen

enzymatic activitygene expressionhuman hepatocytesmetabolismtest guideline

Substanzen

RNA, MessengerCytochrome P-450 Enzyme SystemCytochrome P-450 Enzyme InducersCytochrome P-450 CYP2B6Cytochrome P-450 CYP3A

Autor:innen und Institutionen

  • UK Health Security Agency, Dept of Toxicology, Radiation, Chemical, Climate and Environmental Hazards (RCCE), Harwell Campus, Chilton, United Kingdom.

Zitieren

APA

Quartermain, E., Zhang, J., Marczylo, T., Gant, T. W., & Jacobs, M. N. (2026). HepaRGTM CYP induction test method augmentation part 2: Study supported by mRNA analysis. ALTEX - Alternatives to Animal Experimentation. https://doi.org/10.14573/altex.2606132

Vancouver

Quartermain E, Zhang J, Marczylo T, Gant TW, Jacobs MN. HepaRGTM CYP induction test method augmentation part 2: Study supported by mRNA analysis. ALTEX - Alternatives to Animal Experimentation. 2026. doi:10.14573/altex.2606132

BibTeX
@article{Quartermain2026,
  author = {Quartermain, Emma and Zhang, Jinkang and Marczylo, Tim and Gant, Timothy W and Jacobs, Miriam N},
  title = {HepaRGTM CYP induction test method augmentation part 2: Study supported by mRNA analysis},
  journal = {ALTEX - Alternatives to Animal Experimentation},
  year = {2026},
  doi = {10.14573/altex.2606132}
}
Kostenlos starten →